1. Home
  2. ABVE vs NXTC Comparison

ABVE vs NXTC Comparison

Compare ABVE & NXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Above Food Ingredients Inc.

ABVE

Above Food Ingredients Inc.

N/A

Current Price

$0.56

Market Cap

36.4M

ML Signal

N/A

Logo NextCure Inc.

NXTC

NextCure Inc.

HOLD

Current Price

$11.09

Market Cap

41.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABVE
NXTC
Founded
2019
2015
Country
Canada
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.4M
41.7M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
ABVE
NXTC
Price
$0.56
$11.09
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$23.00
AVG Volume (30 Days)
2.2M
49.4K
Earning Date
07-09-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$22,378,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.32
$0.34
52 Week High
$6.56
$15.74

Technical Indicators

Market Signals
Indicator
ABVE
NXTC
Relative Strength Index (RSI) 35.90 48.64
Support Level N/A $10.73
Resistance Level $1.07 $13.94
Average True Range (ATR) 0.14 1.26
MACD -0.00 0.03
Stochastic Oscillator 5.40 31.75

Price Performance

Historical Comparison
ABVE
NXTC

About ABVE Above Food Ingredients Inc.

Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.

About NXTC NextCure Inc.

NextCure Inc is a clinical-stage biopharmaceutical company that is focused on advancing inventive medicines that treat cancer patients that do not respond to, or that have disease progression on, current therapies, through the use of targeted therapies including antibody-drug conjugates. The company's product candidates include NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.

Share on Social Networks: